Package 65862-309-30

{"route": ["ORAL"], "spl_id": "34bf0456-37d0-4d7d-a585-1555b7bc9373", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "unii": ["0J48LPH2TH", "NW2RTH6T2N"], "rxcui": ["857166", "857174"], "spl_set_id": ["35019655-9a30-4305-a262-936ad0e73071"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (65862-309-01)", "package_ndc": "65862-309-01", "marketing_start_date": "20090709"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (65862-309-30)", "package_ndc": "65862-309-30", "marketing_start_date": "20090709"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (65862-309-99)", "package_ndc": "65862-309-99", "marketing_start_date": "20090709"}], "brand_name": "Fosinopril Sodium and Hydrochlorothiazide", "product_id": "65862-309_34bf0456-37d0-4d7d-a585-1555b7bc9373", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "65862-309", "generic_name": "Fosinopril Sodium and Hydrochlorothiazide", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosinopril Sodium and Hydrochlorothiazide", "active_ingredients": [{"name": "FOSINOPRIL SODIUM", "strength": "20 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}], "application_number": "ANDA079245", "marketing_category": "ANDA", "marketing_start_date": "20090709", "listing_expiration_date": "20261231"}